The Series B funds will support the launch of a Phase I/II clinical trial for AIR-001 to advance its RNA editing pipeline.

Single-cell gene sequencing has changed the way scientists understand life at the smallest level. It lets researchers study ...

In this week’s edition of InnovationRx, we look at Trump's massive health agency layoffs, Palantir’s trade secret lawsuit, ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

These are the symptoms of colorectal cancer. Learn about its causes, risks, and the importance of early detection.

A new suggestion that complexity increases over time, not just in living organisms but in the nonliving world, promises to ...

It comes on the heels of the FDA's top vaccine scientist Peter Marks' exit from the agency, which will be effective April 5.

Acquired resistance genes may allow bacteria to degrade or chemically modify antibiotics, rendering them ineffective. They ...

A research group led by Gian Gaetano Tartaglia, Principal Investigator at the Italian Institute of Technology (IIT), ...

Oxford Nanoimaging (ONI), a leader in super-resolution microscopy, is revolutionizing lipid nanoparticle (LNP) analysis with ...

Vutrisiran improved mortality and recurrent CV risks independent of disease severity and improved several other endpoints for ...

The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...